Literature DB >> 11343059

New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment.

M Mukamel1, G Horev, M Mimouni.   

Abstract

Milk of calcium developed in 2 children with juvenile dermatomyositis. The fluid of the collection contained macrophages, interleukin-6, IL-1, and tumor necrosis factor. The patient who had dystrophic calcinosis had a dramatic improvement with the introduction of alendronate. These findings suggest that calcinosis of juvenile dermatomyositis may be mediated by activated macrophages and that alendronate can be an effective treatment for this condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343059     DOI: 10.1067/mpd.2001.112473

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  26 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

Review 2.  Imaging of muscle disorders in children.

Authors:  Karl Johnson; Penny J C Davis; J Katharine Foster; Janet E McDonagh; Clive A J Ryder; Taunton R Southwood
Journal:  Pediatr Radiol       Date:  2006-06-15

Review 3.  Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis.

Authors:  Lauren M Pachman; Adele L Boskey
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

4.  Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis.

Authors:  Takako Miyamae; Fumie Sano; Remi Ozawa; Tomoyuki Imagawa; Yoshiaki Inayama; Shumpei Yokota
Journal:  Pediatr Rheumatol Online J       Date:  2010-02-04       Impact factor: 3.054

Review 5.  Treatment of inflammatory myopathies.

Authors:  A C Cordeiro; D A Isenberg
Journal:  Postgrad Med J       Date:  2006-07       Impact factor: 2.401

6.  Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy.

Authors:  Hiroko Mori; Yosuke Okada; Kunihiro Yamaoka; Kazuyoshi Saito; Yoshiya Tanaka
Journal:  J Bone Miner Metab       Date:  2011-06-28       Impact factor: 2.626

7.  Electric shock wave lithotripsy (ESWL) as a pain control measure in dermatomyositis with calcinosis cutis-old method, new discovery.

Authors:  Alice Y K Chan; Edmund Li
Journal:  Clin Rheumatol       Date:  2004-11-24       Impact factor: 2.980

8.  Unusual Idiopathic Calcinosis Cutis Universalis in a Child.

Authors:  Derya Alabaz; Neslihan Mungan; Mehmet Turgut; Cemil Dalay
Journal:  Case Rep Dermatol       Date:  2009-08-28

Review 9.  Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome.

Authors:  Tadashi Nakamura; Kei Hirakawa; Hirokazu Takaoka; Ken-Ichi Iyama
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

10.  Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies.

Authors:  Naomi Eidelman; Alan Boyde; Andrew J Bushby; Peter G T Howell; Jirun Sun; Dale E Newbury; Frederick W Miller; Pamela G Robey; Lisa G Rider
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.